Know Cancer

or
forgot password


Phase 3
18 Years
N/A
Not Enrolling
Both
Anemia

Thank you

Trial Information


Inclusion Criteria:



- Body weight >/=99 lbs

- ECOG 0-2

- Anemia results from cancer, chemotherapy, radiotherapy or an association with
hormonal therapy or immunotherapy

- Screening hemoglobin level of

Type of Study:

Interventional

Study Design:

Primary Purpose: Treatment

Authority:

United States: Food and Drug Administration

Study ID:

CR010939

NCT ID:

NCT00083486

Start Date:

February 2004

Completion Date:

October 2004

Related Keywords:

  • Anemia
  • Anemia

Name

Location

Charleston Hematology OncologyCharleston, South Carolina  29403
Northeast Urology ResearchConcord, North Carolina  28025
Mid Ohio Oncology HematologyColumbus, Ohio  43213
Drexel University College of MedicinePhiladelphia, Pennsylvania  19129
Heritage Physician Group-OncologyHot Springs, Arkansas  71913
Spalding Oncology ServicesGriffin, Georgia  30224
Southern Illinois HematologyCentralia, Illinois  62801
BioLab ResearchRockville, Maryland  20852
Slocum-Dickson Medical Group, PCNew Hartford, New York  13413
Caroline Cancer CenterAiken, South Carolina  29403
Charleston Cancer CareCharleston, South Carolina  29406
Volunteer Research GroupKnoxville, Tennessee  37920